SCHEMBL27012267

SCHEMBL27012267

CC1(C)c2ccccc2-c2ccc(-c3cc(Nc4ccc(-c5cccc6ccccc56)c(-c5ccc6c(c5)C(C)(C)c5ccccc5-6)c4)ccc3-c3cccc4ccccc34)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PDK2 Q15119 3/20 0.35
▸ CA12 O43570 3/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ MCL1 Q07820 1/20 0.33
▸ ACMSD Q8TDX5 1/20 0.33
▸ ENPP3 O14638 1/20 0.33
▸ ENPP1 P22413 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ STK10 O94804 1/20 0.32
▸ SLK Q9H2G2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ NTSR1 P30989 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25569223 0.91 ALDH1A1 (0.38) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL25568648 0.90 PDK2 (0.40) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL10034426 0.90 MCL1 (0.39) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL31245664 0.88 ALDH1A1 (0.39) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL27012236 0.88 PDK2 (0.39) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL29407519 0.87 PDK2 (0.42) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL13367457 0.87 PDK2 (0.42) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL21726976 0.87 ALDH1A1 (0.35) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL23137765 0.86 PDK2 (0.41) ALDH1A1MAPTPDK2CA12CA1
SCHEMBL31058374 0.86 PDK2 (0.41) ALDH1A1MAPTPDK2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1034/4885MAPT 724/4885PDK2 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback